Conference Coverage

VIDEO: Weight loss cut risk of breast cancer


 

REPORTING FROM SABCS 2017

– A new analysis from the Women’s Health Initiative Observational Study gives postmenopausal women yet another reason to mind their weight. Results showed that women losing at least 5% of their body weight had a significant 12% reduction in adjusted breast cancer risk relative to peers who maintained a stable weight, reported lead author Rowan Chlebowski, MD, PhD, research professor in the department of medical oncology and therapeutics research at City of Hope in Duarte, Calif. Findings were much the same regardless of whether women were of normal weight, overweight, or obese at baseline. Dr. Chlebowski discussed the implications for patient counseling and insurance coverage of weight loss interventions, as well as planned research that will assess the physiologic mechanisms at play in a video interview.

Recommended Reading

VIDEO: Dr. Matteo Lambertini answers questions on temporary ovarian suppression
MDedge Hematology and Oncology
Ribociclib plus standard of care improves PFS in premenopausal HR+/HER2-negative breast cancer
MDedge Hematology and Oncology
Dose intensification gets more mileage out of adjuvant chemo
MDedge Hematology and Oncology
No evidence for perioperative AI benefit in early ER/PR+ breast cancer
MDedge Hematology and Oncology
VIDEO: 5 years of additional AI no better than 2 in HR+ breast cancer
MDedge Hematology and Oncology
Acupuncture significantly reduces AI-associated arthralgias
MDedge Hematology and Oncology
VIDEO: CDK4/6, ET, LHRH combo improves PFS in premenopausal breast cancer
MDedge Hematology and Oncology
Shaping practice: Z1071 continues to redefine axillary management
MDedge Hematology and Oncology
2 = 5 for additional AI therapy for postmenopausal HR+ breast cancer
MDedge Hematology and Oncology
Adjuvant trastuzumab for 1 year remains standard of care for early HER2+ breast cancer
MDedge Hematology and Oncology